Jonathan C Fox
CIK 1655016 · See Remarks · last filed 2026-04-03
Jonathan C Fox is a corporate insider who has filed 38 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for EWTX, was dated Apr 3, 2026. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $853.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$853.8K
3
38
-$6.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | Director | 24,514 | $34.83 | $853.8K | $300.4K | 11 | 2026-04-03 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | See Remarks | 380,967 | — | — | -$7.28M | 24 | 2020-09-18 |
| MyoKardia, Inc. (MYOK) Delisted | Chief Medical Officer | 240,997 | — | — | $30.0K | 2 | 2016-05-06 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | EWTX | Grant (A) | +339 | $0 | EDGAR |
| 2026-01-05 | EWTX | Grant (A) | +473 | $0 | EDGAR |
| 2025-11-13 | EWTX | Buy (P) | +10,700 | $199.4K | EDGAR |
| 2025-10-02 | EWTX | Grant (A) | +728 | $0 | EDGAR |
| 2025-07-02 | EWTX | Grant (A) | +858 | $0 | EDGAR |
| 2025-06-18 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | EWTX | Grant (A) | +559 | $0 | EDGAR |
| 2024-06-12 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2023-12-28 | EWTX | Buy (P) | +10,857 | $101.0K | EDGAR |
| 2023-06-14 | EWTX | Grant (A) | — | $0 | EDGAR |